Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$1.67 - $2.35 $34,442 - $48,466
-20,624 Reduced 67.38%
9,984 $18,000
Q3 2022

Nov 14, 2022

SELL
$1.81 - $2.76 $45,313 - $69,096
-25,035 Reduced 44.99%
30,608 $59,000
Q2 2022

Aug 22, 2022

BUY
$1.34 - $5.34 $2,141 - $8,533
1,598 Added 2.96%
55,643 $115,000
Q4 2021

Feb 14, 2022

BUY
$5.23 - $7.18 $143,495 - $196,997
27,437 Added 103.12%
54,045 $347,000
Q3 2021

Nov 15, 2021

BUY
$5.94 - $8.75 $85,494 - $125,938
14,393 Added 117.83%
26,608 $165,000
Q2 2021

Aug 12, 2021

BUY
$7.54 - $9.79 $55,109 - $71,555
7,309 Added 148.98%
12,215 $97,000
Q1 2021

May 17, 2021

SELL
$4.76 - $11.25 $14,670 - $34,672
-3,082 Reduced 38.58%
4,906 $47,000
Q3 2020

Nov 13, 2020

SELL
$2.3 - $3.72 $4,977 - $8,050
-2,164 Reduced 21.32%
7,988 $20,000
Q2 2020

Aug 14, 2020

BUY
$1.33 - $3.63 $1,506 - $4,112
1,133 Added 12.56%
10,152 $32,000
Q1 2020

May 14, 2020

SELL
$1.27 - $2.33 $2,500 - $4,587
-1,969 Reduced 17.92%
9,019 $13,000
Q3 2019

Nov 13, 2019

BUY
$1.93 - $4.21 $7,169 - $15,640
3,715 Added 51.08%
10,988 $26,000
Q2 2018

Aug 10, 2018

SELL
$4.43 - $5.14 $8,753 - $10,156
-1,976 Reduced 21.36%
7,273 $35,000
Q1 2018

May 17, 2018

SELL
$4.65 - $5.9 $21,413 - $27,169
-4,605 Reduced 33.24%
9,249 $48,000
Q4 2017

Feb 13, 2018

BUY
$4.32 - $5.52 $59,849 - $76,474
13,854
13,854 $65,000

Others Institutions Holding CMRX

About CHIMERIX INC


  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $85M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.